“Increasing Preference for Single-Injection Formulations”
The viscosupplementation market is witnessing significant growth, driven by the rising prevalence of osteoarthritis and other joint disorders that necessitate effective pain management solutions. One prominent trend in the global viscosupplementation market is the increasing preference for single-injection formulations over traditional multi-injection regimens. Such shift is largely driven by patient convenience and compliance, as single-injection products reduce the need for multiple visits to healthcare providers. For instance, the introduction of Durolane, a single-injection hyaluronic acid treatment for knee osteoarthritis, has gained popularity due to its effectiveness and the convenience it offers patients. In addition, the growing emphasis on minimally invasive procedures in orthopedic care is propelling the demand for these innovative solutions. As more patients seek effective, convenient treatments for osteoarthritis and joint pain, the adoption of single-injection viscosupplementation products is expected to drive significant growth in the global market, enhancing patient satisfaction and treatment outcomes.
